Anti-carbamylated protein (anti-CarP) antibodies have been described in rheumatoid arthritis (RA) and arthralgia patients at risk of developing RA.
In this study,
the researcher observed that anti-carbamylated protein (anti-CarP) antibodies
occur in almost all forms of early arthritis. For the future prospects, triple
positivity score may also be used to identify future RA patients among
individuals that do not yet display clinical symptoms as showed in this study.
Anti-carbamylated
protein (anti-CarP) antibodies have been described in rheumatoid arthritis (RA)
and arthralgia patients at risk of developing RA. To what extent these
autoantibodies are specific for RA is unknown. Therefore, we investigated the
diagnostic performance of the presence of anti-CarP antibodies for RA in a
setting of early arthritis.
Anti-CarP
antibodies were detected using carbamylated fetal calf serum as substrate.
Anti-CCP2 antibodies were measured using enzyme-linked immunosorbent assay and
immunoglobulin M (IgM) rheumatoid factor (RF) as part of routine care. Sera
were derived from patients in the Leiden Early Arthritis Clinic cohort obtained
at inclusion. Test characteristics were determined using the fulfillment of the
2010 RA criteria after 1 year as outcome.
In total 2086
early arthritis patients were studied regarding the presence of anti-CarP
antibodies. We observed that the sensitivity and specificity of the presence of
anti-CarP antibodies for RA were 44 % and 89 %, respectively. As a reference,
sensitivity and specificity of the presence of anti-CCP2 antibodies were 54 %
and 96 %, respectively, and of IgM-RF 59 % and 91 %. Patients harboring
anti-CarP antibodies not classified as RA were mainly diagnosed with
undifferentiated arthritis and less frequently reactive arthritis and psoriatic
arthritis.
Anti-CarP
antibodies are predominantly present in RA but can also be detected in other
forms of arthritis.
Arthritis Research and therapy
The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis
Jing Shi et al.
Comments (0)